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General anesthetics produce a widespread neurodepression in the central nervous system by enhancing inhibitory 
neurotransmission and reducing excitatory neurotransmission. However, the action mechanisms of general 
anesthetics are not completely understood. Moreover, the general anesthetic state comprises multiple components 
(amnesia, unconsciousness, analgesia, and immobility), each of which is mediated by different receptors and 
neuronal pathways. Recently, neurotransmitter- and voltage-gated ion channels have emerged as the most likely 
molecular targets for general anesthetics. The γ-aminobutyric acid type A (GABAA) receptors are leading candidates 
as a primary target of general anesthetics. This review summarizes current knowledge on how anesthetics modify 
GABAA receptor function.  (Korean J Anesthesiol 2010; 59: 3-8)
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    The introduction of general anesthesia is evaluated as one of 
the prominent achievements for the development of modern 
medical science. Since William Morton conducted an operation 
by using general anesthetics for the first time, the mechanism 
has not been clearly understood yet.
    Still, there is no objectively agreed definition of general 
anesthesia. The behavioral responses are various depending 
on the concentration of anesthetics, and can include amnesia, 
excitation, analgesia, hypnosis and hyperreflexia in a low 
concentration, and deep sedation, muscle relaxation, and 
reduced motor and autonomic response to noxious stimuli in a 
high concentration [1].
    Many studies have been recently done on the mechanisms of 
general anesthesia. Each of the behavioral responses of general 
anesthesia selectively functions on different parts of the brain 
and various molecular targets. In particular, the binding sites 
of ion channel receptors are closely related to the functional 
sites of general anesthetics. Out of various ion channels, the 
γ-aminobutyric acid type A (GABAA) subunit receptor has 
been known to play the most important role as a functional 
site of general anesthetics [1-5]. Therefore, in this review, the 
physiologic action of the GABAA receptor and the association 
between various behavioral responses to general anesthetics 
and the GABAA receptor are summarized from recent pieces 
of research. In addition, other ion channels that are known to 
be other functional sites of general anesthetics are also briefly 
introduced. 4 www.ekja.org
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Anesthetic Actions on Different Regions of 
the Central Nervous System (CNS)
    The association between the functions of general anesthetics 
and specific sites of CNS has been recently discovered. The 
immobility function of inhalation anesthetics by noxious stimuli 
primarily acts on the spinal cord, not being connected with the 
brain [6].
    Although there is insufficient evidence to prove the association 
between specific sites of the brain and the functional sites of 
general anesthetics, there are some cases that are gradually 
revealed. The amnesia effect of general anesthetics is closely 
related with the hippocampus [7,8]. Sedation is related to 
the neocortex [9] and thalamus [10], and hypothalamus is 
presumably the hypnotic action part.
Molecular Targets of General Anesthetics 
    Cells of the brain communicate with each other using a wide 
variety of chemical neurotransmitters. Such neurotransmitters, 
responding to electrical signals, are released into synapse. 
Depending on the functions, they are classified as excitatory 
neurotransmitters or inhibitory neurotransmitters. Excitatory 
neurotransmitters, for example glutamate and acetylcholine, 
cause depolarization. Conversely, inhibitory neurotransmitters, 
such as α-aminobutyric acid (GAGA) and glycine, reduce 
postsynaptic activity. The free neurotransmitters bind with 
ion channel receptors to control the flow of ions. The control 
of cell electrical activity by ion channels is closely linked 
with the physiologic action of anesthetics and the various 
behavioral response patterns to them (Table 1) [11]. Among 
ion channels, GABAA, glycine, nicotinic acetylcholine, and 
N-methyl-D-aspartate (NMDA) receptors show sensitivity to 
general anesthetics [1-4]. Some of the volatile anesthetics also 
act on potassium channels and voltage-gated channels (sodium, 
calcium) [12-14]. Typically, general anesthetics potentiate the 
activation of inhibitory postsynaptic channels or inhibit the 
activation of excitatory synaptic channels [11].
GABAA Receptors 
Structure and physiology of GABAA receptors 
    GABA is the major inhibitory neurotransmitter in the 
mammalian brain, and as many as one-third of all synapses 
are GABAergic [15]. Most inhibition is mediated by GABAA 
receptors, which are chloride-permeable ligand-gated ion 
channels. Activation of GABAA receptors generally leads to an 
influx of chloride, hyperpolarization of the cell membrane, 
shunting of excitatory input, and reduced excitability of the 
neurons [11]. The GABAA receptor itself is a heteropentameric 
complex composed of five different subunits, and 19 subunits 
(α 1-6, β 1-3, γ 1-3, δ, ε, ψ, π and ρ 1-3) have been known until 
now [16]. The combinations of α, β, and γ subunits are the 
most common with the ratio of 2 : 2 : 1. The γ subunit may be 
replaced by a δ or ε subunit, depending on the brain region. 
The subunit composition can alter the biophysical properties of 
the receptors and drug sensitivity [17]. 
Table 1. Physiological and Pharmacological Roles for Ion Channels Targets of Anesthetics
Ion channel Cellular function Physiological and pharmacological effects
GABAA receptors
Glycine receptors
Nicotinic acetylcholine receptors
Glutamate receptors
Serotonin receptors
Potassium channels
    K2P channels
    Voltage-gated K
+ 
    Channels
Sodium channels
Calcium channels
Increased chloride permeability;
  membrane hyperpolarization;
  inhibition of excitability
Increased chloride permeability;
  membrane hyperpolarization; 
  inhibition of excitability
Increased permeability of monovalent cations 
  and calcium; release of neurotransmitters
Fast excitatory neurotransmission;
  increased permeability of calcium, sodium 
  and magnesium
5-HTR3, nonspecific cation conductance leading to
  membrane depolarization
Modulation of resting potential and excitability
Membrane repolarization
Generation and propagation of action potentials
Presynaptic neurotransmitter release
Anxiolysis; sedation; amnesia; 
  anticonvulsive action; muscle relaxation
Spinal reflexes; startle impulse; 
  major inhibitory receptor in spinal cord
Memory; nociception; autonomic functions; 
  mutations associated with epilepsy
Perception; learning and memory; nociception
Neuronal excitation
Nonspecific role
Basic neuronal function
Nerve conduction
Nonspecific role
GABAA: γ-aminobutyric acid A, 5-HTR3: 5-hydroxytryptamine receptor, K2P channel: two-pore potassium channel.5 www.ekja.org
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    GABAA receptors clustered at postsynaptic terminals are 
activated by a near-saturating concentration of GABA. GABA 
transmits information to inhibitory synapse by generating the 
fast and transient inhibitory postsynaptic currents (IPSCs) (Fig. 1) 
[18]. For many years, enhancement of fast synaptic inhibition 
was widely thought to be the primary mechanism underlying 
the actions of many GABAergic drugs.
    Over the past decade, however, a persistent form of tonic 
inhibition has been identified in several brain regions. Tonic 
currents are known to be generated as GABA acts on the GABAA 
receptor at the extrasynapse, not on synapse (Fig. 1) [8,19]. This 
tonic inhibitory conductance is generated by high-affinity, 
slowly desensitizing GABAA receptors that are activated by low 
ambient concentration of GABA [20-22]. Tonic currents are 
generated in several types of cells including CA1 pyramidal 
[8,23], granule cells [24], and interneurons [19,25] of the 
hippocampus. In the hippocampus, the tonic conductance is 
also activated by GABA released by action potential dependent 
vesicular mechanism [26]. The tonic conductance has been 
shown to regulate neuronal excitability and information 
processing [19,27].
Anesthetic actions of GABAA receptors 
    General anesthetics enhance the action of the neurotran-
smitter GABA on the GABAA receptor. They potentiate IPSCs 
generated by the synaptic GABAA receptor [1,2,28]. In addition, 
several anesthetics have been shown to reduce desensitization 
of GABAA receptors [28,29] (Fig. 2A and B). At higher concen-
tration, anesthetics directly activate GABAA receptors without 
the help of GABA [28]. 
    The tonic currents generated by the extrasynaptic GABAA 
receptors are also potentiated by general anesthetics [7,21,22]. 
The enhancement of inhibitory currents by general anesthetics 
is called charge transfer. The increase of charge transfer by tonic 
currents is 2-3 times larger than that by miniature inhibitory 
postsynaptic currents (mIPSCs) (Fig. 2C) [23]. Thus, the tonic 
current function of anesthesia is drawing increasing attention. 
The difference in pharmacological and kinetic properties by 
synpatic or extrasynaptic GABAA receptors has been known 
to be caused by the different composition of the subunits [8]. 
Hence, a number of studies are performed on the various 
functions of general anesthetics and their relations with GABAA 
subunits receptors.
    Volatile anesthetics are low-potency compounds that influence 
a variety of receptors at clinically relevant concentrations [1]. In 
addition, behavioral testing with volatile anesthetics is difficult 
for practical reasons. Nonetheless, α 1, β 1 and β 3 subunits of the 
Fig. 1. Synaptic and extrasynaptic activation of γ-aminobutyric acid 
subtype A (GABAA) receptors. Action potential dependent release of 
GABA into the synaptic cleft transiently activates GABAA receptors in 
the postsynaptic membrane. This generates inhibitory postsynaptic 
currents (IPSCs). Extrasynaptic GABAA receptors are activated by low 
concentrations of GABA in the extracellular space. These receptors 
have low desensitization rates and can produce a tonic current (con-
ti  nuous current). The tonic current is revealed by application of a 
GABAA antagonist, Bicuculline, which inhibits the current. Many 
general anesthetics enhance the tonic current at clinically relevant 
con  centrations. ITonic represents the amplitude of the steady state 
current.
Fig. 2. Potentiation of γ-aminobutyric acid subtype A (GABAA) 
receptor-mediated inhibitory synaptic and tonic current by the 
general anesthetics. (A) The prolongation of miniature inhibitory 
synaptic currents (mIPSCs) by the slowing of current decay is shown. 
(B) Propofol prolongs the time-course of mIPSCs and slightly 
increases the peak amplitude of mIPSCs. (C) The schematic drawings 
used to calculate charge transfer (shaded area). Anesthetics produce 
a greater increased in charge transfer associated with the tonic 
current compared with mIPSCs. 6 www.ekja.org
Molecular mechanisms of general anesthesia Vol. 59, No. 1, July 2010
GABAA receptor have been known as the important functional 
sites of volatile anesthetics [30,31]. Particularly, two amino acids 
in the of α 1 subunit are critical for anesthetic action: serine 
270 in the transmembrane 2 region and alanine 291 near the 
extracellular regions of transmembrane 3 [30]. Various GABAA 
subunit receptors have been recognized as being related to the 
inhibition of the nervous system. 
    The impairment of memory is one of the most potent effects 
of many general anesthetics. Memory is particularly sensitive to 
general anesthetics because amnesia occurs at concentrations 
well below those that cause sedation and analgesia [32]. 
The dose of etomidate that impairs memory is considerably 
lower than the dose that causes immobility [7]. In the case of 
isoflurane, reduced cognitive function and amnesia are caused 
at a concentration remarkably lower than 1 MAC [8]. GABAergic 
tonic currents occurring in the hippocampus are closely 
connected with memory, playing an important role in cognition 
[7,8]. Low concentration of propofol [33], etomidate [7], and 
isoflurane [8] enhance the tonic currents through the α 5 GABAA 
receptors in the hippocampus. Although the ratio of the GABAA 
receptor subunits that have α 5 is low, they are distributed at the 
extrasynapse of the hippocampus in a relatively high ratio [34,35]. 
Some researches show that α 5GABAA subunit receptors are 
related to learning and memory. The mice with chromosomal 
depletion (α 5-/-) at the α 5GABAA subunit receptor showed 
better hippocampus-dependent learning than those of the wild 
type [36]. The memory of mice was improved when the position 
105 histidine of α5 subunit was substituted with arginine 
(α 5His105Arg) [37]. Therefore, it can be assumed that general 
anesthetics potentiate the tonic currents acting on the α 5GABAA 
receptor in the hippocampus, which can be considered as one 
of the amnesia mechanisms that occur during anesthesia.
    Sedation refers to a decreased level of arousal, as indicated 
by longer response times, decreased motor activity, and slurred 
speech. In animal models, sedation is assessed by the levels of 
reduced motor activity and arousal [38]. Sedation by etomidate 
occurs at another isoform of the α 5GABAA receptor related 
to amnesia. In β 2 subunit (β 2Asn265Ser) mice, low doses of 
etomidate failed to reduce spontaneous locomotor activity, 
which implies that the sedative actions of etomidate depend 
on GABAA receptors containing the β 2 subunit [39]. Diazepam, 
which has distinct sedation activity, is related to the position 
101 histidine of the α 1 subunit [40]. The α 1 and β 2 subunit-
containing GABAA receptors in the neocortex are thought to 
contribute to the sedative actions of several inhaled anesthetics 
[9]. Tonic current in the thalamic VB neurons may contribute to 
the sedative action [10].
    Hypnosis typically requires higher concentrations of 
anesthetics than sedation and is often measured by the loss 
of the righting reflex in rodents [38]. Etomidate induced 
hypnosis also depends on the β 3 (Asn256Met) subunit, being 
partly related with the GABAA receptor β2 subunit, as well 
[41]. Hypnosis by anesthetics is presumed to be related with 
the thalamus [42] and the tuberomammillary nucleus of the 
hypothalamus [43], though it is yet unproved.
Other Ion Channels 
Glycine receptors 
    The glycine receptor is known as an important target of 
inhalation anesthetics in the spinal cord [6]. This receptor, 
composed of four α subunits and a single β subunit, shows 
the inhibitory function by enhancing the inflow of chloride ions 
into the cells, the same as GABAA receptors. It has been known 
that the glycine receptor is particularly strong for the loss of 
response to a painful stimulus, which appears to be determined 
predominantly by actions in the spinal cord [6,44].
Nicotinic acetylcholine receptors 
    Nicotinic acetylcholine receptors are also involved in the 
control of synaptic conduction in CNS. Activation of this 
receptor causes excitatory postsynaptic currents (EPSCs) by the 
inflow of cation into the cells. It has been known that general 
anesthetics show the repressive function by blocking EPSCs at a 
low concentration [45].
Glutamate receptors 
    Ionotropic glutamate receptors generate EPSCs by the perme-
ation of cation as well. Inhaled anesthetics block excitatory 
neurotransmission by inhibiting not only postsynaptic 
glutamate receptors but also the glutamate release from 
presynapse [46,47].
Potassium channels 
    Volatile anesthetics activate the two-pore-domain potassium 
channels, which plays an important role in forming the resting 
membrane potential [5,48]. Activation of this channel causes 
inhibition of the neuron activity and hyperpolarization by 
increasing the conductance of potassium ions.
Sodium channels 
    The voltage-gated sodium channel plays an important role 
in axonal conduction, synaptic integration, and neuronal 
excitation [5]. General anesthetics, particularly, inhibit the 
presynaptic voltage-gated sodium channels in glutamatergic 7 www.ekja.org
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synapse, which inhibits the excitation of the neuron by blocking 
the release of presynaptic neurotransmitters [5,13]. 
Summary 
    It has been conventionally known that general anesthetics 
act on CNS non-specifically. However, there has recently 
been much progress in understanding the functional 
mechanisms, as well. Most of the general anesthetics act on 
various neurotransmitter-gated ion channels. The most known 
representative target is the GABAA receptor. Especially thanks 
to the advancement in genetic engineering, the ways in which 
various behavioral response patterns are selectively related to 
the GABAA receptor subunits in specific parts of the brain have 
been gradually revealed. Such progress not only increases the 
understanding of the mechanisms of general anesthetics, but 
also provides help in developing novel and selective anesthetics.
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